EOM Pharmaceutical Holdings Inc (IMUC)
0.1840
+0.03
(+18.68%)
USD |
OTCM |
May 03, 16:00
EOM Pharmaceutical Holdings 1 Year Total Returns (Daily): -38.70% for May 3, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
May 03, 2024 | -38.70% |
May 02, 2024 | -26.23% |
May 01, 2024 | -15.79% |
April 30, 2024 | -23.88% |
April 29, 2024 | -23.88% |
April 26, 2024 | -43.44% |
April 25, 2024 | -43.44% |
April 24, 2024 | -41.66% |
April 23, 2024 | -43.44% |
April 22, 2024 | -43.44% |
April 19, 2024 | -43.44% |
April 18, 2024 | -49.57% |
April 17, 2024 | -57.13% |
April 16, 2024 | -43.44% |
April 15, 2024 | -59.39% |
April 12, 2024 | -59.39% |
April 11, 2024 | -43.18% |
April 10, 2024 | -62.53% |
April 09, 2024 | -56.64% |
April 08, 2024 | -37.46% |
April 05, 2024 | -68.57% |
April 04, 2024 | -43.43% |
April 03, 2024 | -43.43% |
April 02, 2024 | -32.14% |
April 01, 2024 | -45.71% |
Date | Value |
---|---|
March 28, 2024 | -56.57% |
March 27, 2024 | -47.71% |
March 26, 2024 | -34.29% |
March 25, 2024 | -21.74% |
March 22, 2024 | -21.74% |
March 21, 2024 | -37.14% |
March 20, 2024 | -37.14% |
March 19, 2024 | -47.60% |
March 18, 2024 | -47.38% |
March 15, 2024 | -54.30% |
March 14, 2024 | -57.14% |
March 13, 2024 | -43.70% |
March 12, 2024 | -51.47% |
March 11, 2024 | -51.08% |
March 08, 2024 | -62.73% |
March 07, 2024 | -51.47% |
March 06, 2024 | -53.41% |
March 05, 2024 | -63.79% |
March 04, 2024 | -63.79% |
March 01, 2024 | -50.34% |
February 29, 2024 | -38.83% |
February 28, 2024 | -50.21% |
February 27, 2024 | -48.91% |
February 26, 2024 | -47.39% |
February 23, 2024 | -47.39% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-93.54%
Minimum
May 20 2019
373.3%
Maximum
Jan 06 2023
12.11%
Average
6.67%
Median
Sep 24 2020
1 Year Total Returns (Daily) Benchmarks
CEL-SCI Corp | -27.23% |
AIM ImmunoTech Inc | -15.65% |
IGC Pharma Inc | 53.98% |
NovaBay Pharmaceuticals Inc | -90.79% |
Protalix BioTherapeutics Inc | -63.81% |